BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31326268)

  • 1. Vascular Complications and Procedures Following Transcatheter Aortic Valve Implantation.
    Raju S; Eisenberg N; Montbriand J; Cusimano RJ; Feindel C; Ouzounian M; Horlick E; Osten M; Tsang W; Roche-Nagle G
    Eur J Vasc Endovasc Surg; 2019 Sep; 58(3):437-444. PubMed ID: 31326268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in vascular complications and associated treatment strategies following transfemoral transcatheter aortic valve replacement.
    Ullery BW; Jin R; Kirker EB; Hayes G; Siwek L; Brevig J; Hodson RW; Spinelli KJ
    J Vasc Surg; 2020 Oct; 72(4):1313-1324.e5. PubMed ID: 32169358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computed Tomographic Angiography-Derived Risk Factors for Vascular Complications in Percutaneous Transfemoral Transcatheter Aortic Valve Implantation.
    Urbach J; Hou CR; Lesser JR; Stanberry LI; Garberich RF; Caye D; Sorajja P; Gössl M
    Am J Cardiol; 2019 Jul; 124(1):98-104. PubMed ID: 31029410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence, Predictors, and Impact of Vascular Complications After Transfemoral Transcatheter Aortic Valve Implantation With the SAPIEN 3 Prosthesis.
    van Kesteren F; van Mourik MS; Vendrik J; Wiegerinck EMA; Henriques JPS; Koch KT; Wykrzykowska JJ; de Winter RJ; Piek JJ; van Lienden KP; Reekers JA; Vis MM; Planken RN; Baan J
    Am J Cardiol; 2018 May; 121(10):1231-1238. PubMed ID: 29703437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence, Prognosis and Predictors of Major Vascular Complications and Percutaneous Closure Device Failure Following Contemporary Percutaneous Transfemoral Transcatheter Aortic Valve Replacement.
    Batchelor W; Patel K; Hurt J; Totten J; Burroughs P; Smith G; Cuervo M; Davis L; Damluji AA; Epps K; Sherwood M; Barnett S; Geloo N; Yazdani S; Sarin E; Ryan L; Noel T
    Cardiovasc Revasc Med; 2020 Sep; 21(9):1065-1073. PubMed ID: 31974033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standardized Measurement of Femoral Artery Depth by Computed Tomography to Predict Vascular Complications After Transcatheter Aortic Valve Implantation.
    Durand E; Penso M; Hemery T; Levesque T; Moles G; Tron C; Bouhzam N; Bettinger N; Wong S; Dacher JN; Eltchaninoff H
    Am J Cardiol; 2021 Apr; 145():119-127. PubMed ID: 33460601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of vascular complications following transcatheter aortic valve implantation.
    Perrin N; Ellenberger C; Licker M; Hachulla AL; Cikirikcioglu M; Frei A; Roffi M; Noble S
    Arch Cardiovasc Dis; 2015 Oct; 108(10):491-501. PubMed ID: 26073229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular complications after transcatheter transfemoral aortic valve implantation: Modified sheath-to-femoral artery ratio as a new predictor.
    Çakal S; Çakal B; Karaca O; Güler Y; Özcan ÖU; Güneş HM; Kızılırmak Yılmaz F; Yıldırım A; Boztosun B
    Anatol J Cardiol; 2022 Jan; 26(1):49-56. PubMed ID: 35191386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictability and Outcome of Vascular Complications after Transfemoral Transcatheter Aortic Valve Implantation.
    Uguz E; Gokcimen M; Ali S; Alsancak Y; Bastug S; Ahmet Kasapkara H; Canyigit M; Hıdıroglu M; Sener E
    J Heart Valve Dis; 2016 Mar; 25(2):173-181. PubMed ID: 27989061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence, predictors, impact, and treatment of vascular complications after transcatheter aortic valve implantation in a modern prospective cohort under real conditions.
    Langouet Q; Martinez R; Saint-Etienne C; Behlaj Soulami R; Harmouche M; Aupart M; Le Breton H; Verhoye JP; Bourguignon T
    J Vasc Surg; 2020 Dec; 72(6):2120-2129.e2. PubMed ID: 32276023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of transcatheter aortic valve implantation in patients with coronary heights ≤7 mm: insights from the transcatheter aortic valve implantation Karlsruhe (TAVIK) registry.
    Conzelmann LO; Würth A; Schymik G; Schröfel H; Anusic T; Temme S; Tzamalis P; Gerhardus J; Mukherjee C; Gonska BD; Schmitt C; Mehlhorn U
    Eur J Cardiothorac Surg; 2018 Oct; 54(4):752-761. PubMed ID: 29617804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimalistic Approach for Transcatheter Aortic Valve Implantation (TAVI): Open Vascular Vs. Fully Percutaneous Approach.
    Kedev S; Zafirovska B; Srbinovska-Kostovska E; Antov S; Nikolic A; Dzemali O; Bunc M
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2019 Oct; 40(2):5-14. PubMed ID: 31605589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular Complications and Bleeding After Transfemoral Transcatheter Aortic Valve Implantation Performed Through Open Surgical Access.
    Leclercq F; Akodad M; Macia JC; Gandet T; Lattuca B; Schmutz L; Gervasoni R; Nogue E; Nagot N; Levy G; Maupas E; Robert G; Targosz F; Vernhet H; Cayla G; Albat B
    Am J Cardiol; 2015 Nov; 116(9):1399-404. PubMed ID: 26414600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Iliac Morphology Score Predicts Procedural Mortality and Major Vascular Complications in Transfemoral Aortic Valve Replacement.
    Blakeslee-Carter J; Dexter D; Mahoney P; Ahanchi S; Steerman S; Larion S; Cain B; Panneton JM
    Ann Vasc Surg; 2018 Jan; 46():208-217. PubMed ID: 28689947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility and outcomes of interventional treatment for vascular access site complications following transfemoral aortic valve implantation.
    Seidler T; Hünlich M; Puls M; Hasenfuß G; Jacobshagen C
    Clin Res Cardiol; 2017 Mar; 106(3):183-191. PubMed ID: 27687044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular complications after transcatheter aortic valve implantation and their association with mortality reevaluated by the valve academic research consortium definitions.
    Steinvil A; Leshem-Rubinow E; Halkin A; Abramowitz Y; Ben-Assa E; Shacham Y; Bar-Dayan A; Keren G; Banai S; Finkelstein A
    Am J Cardiol; 2015 Jan; 115(1):100-6. PubMed ID: 25456874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends over the past 4 years in population characteristics, 30-day outcomes and 1-year survival in patients treated with transcatheter aortic valve implantation.
    Avinée G; Durand E; Elhatimi S; Bauer F; Glinel B; Dacher JN; Cellier G; Viart G; Tron C; Godin M; Litzler PY; Cribier A; Eltchaninoff H
    Arch Cardiovasc Dis; 2016; 109(8-9):457-64. PubMed ID: 27342810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iliofemoral artery lumen volume assessment with three dimensional multi-detector computed tomography and vascular complication risk in transfemoral transcatheter aortic valve replacement.
    Hammer Y; Landes U; Zusman O; Kornowski R; Witberg G; Orvin K; Levi A; Codner P; Vaknin-Assa H; Nassar M; Shafir G; Assali A; Hamdan A
    J Cardiovasc Comput Tomogr; 2019; 13(1):68-74. PubMed ID: 30340961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of MANTA vs ProGlide Vascular Closure Device and 30-Day Outcomes in Transfemoral Transcatheter Aortic Valve Implantation.
    Eftychiou C; Eteocleous N; Mitsis A; Zittis I; Papadopoulos K; Petrou A; Adamou M; Kounnos C; Bekos C; Avraamides P
    Tex Heart Inst J; 2022 Sep; 49(5):. PubMed ID: 36269884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes mellitus is not associated with worse vascular outcome following percutaneous transfemoral transcatheter aortic valve implantation.
    Lareyre F; Mialhe C; Bourlon F; Habib Y; Dommerc C; Raffort J
    Acta Cardiol; 2019 Dec; 74(6):480-486. PubMed ID: 30642229
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.